SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company…
Crinetics Pharmaceuticals stock falls after CMO departure announcement…
SAN DIEGO , Dec. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on…
Crinetics Pharmaceuticals hat in den vergangenen Monaten bedeutende Fortschritte erzielt. Allen voran die erfolgreiche US-Zulassung von Paltusotin zur Behandlung von…
The FDA just handed this clinical-stage biotech its golden ticket -- but at a $4.3 billion valuation, the markets already…
The FDA just handed this clinical-stage biotech its golden ticket -- but at a $4.3 billion valuation, the markets already…
Crinetics Pharmaceuticals Inc. (CRNX) kann momentan dank der Zulassung ihres Hauptmedikaments Palsonify (Paltusotine) durch die US-amerikanische Food and Drug Administration…
…
CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of -8.85% and -79.78%, respectively, for the quarter ended June 2025. Do…
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June…
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April…
…
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January…
…
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December…
…
Mit seinen innovativen Therapien für unterversorgte Zielgruppen hat der Megatrend Biopharmazeutika bereits einige attraktive Anlageoptionen für Investoren hervorgebracht. Allen voran…
…
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused…
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September…
…
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July…
Crinetics Pharmaceuticals exec sells shares worth over $645,000…
…
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June…
…
SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May…
Investors interested in the life science sector are well aware of the importance of biotechnology.From finding cures for diseases to…
Crinetics Pharmaceuticals exec sells over $664k in company stock…
Crinetics Pharmaceuticals director Fust sells shares worth over $2.6m…
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.…
Crinetics Pharmaceuticals CFO sells shares worth nearly $300k…
Crinetics Pharmaceuticals (CRNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
…
Crinetics Pharmaceuticals secures $350 million in placement…